23. Remaining Questions: Clinical Outcomes

Although the reduction in Lp(a) is remarkable, the current study did not assess whether this leads to fewer heart attacks or strokes. Experts emphasize that outcome trials measuring these real-world clinical benefits are essential before lepodisiran can be widely recommended.
For more expert perspectives, visit American College of Cardiology.